Silexion Therapeutics SLXN
NASDAQ SLXN
$0.28 +0.00 (+0.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Silexion Therapeutics (SLXN) Capital Expenditures (2023 - 2025)

Updated

Silexion Therapeutics' Capital Expenditures came in at $2,000 for Q4 2025.

Analysis

Silexion Therapeutics (SLXN) Capital Expenditures (2023 - 2025) Analysis & Trends

For FY2025, Silexion Therapeutics' Capital Expenditures was $9,000, down 59.1% from FY2024.

  • Going back by year, Capital Expenditures was $22,000 in FY2024 (+83.3%) and $12,000 in FY2023.
  • The five-year range for quarterly Capital Expenditures is $1,000 (Q2 2025) to $16,000 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Silexion Therapeutics 192,458.84 -19.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 6,000.00
Sep 30, 2024 16,000.00
Mar 31, 2024 6,000.00
Dec 31, 2023 4,000.00
Sep 30, 2023 6,000.00
Jun 30, 2023 2,000.00
API Access

Silexion Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SLXN&period=max&api_key=YOUR_API_KEY